Videos: Respiratory Medicine

In this talk from 16 March 2021, Prof Mona Bafadhel discusses her recent research on the use of inhaled corticosteroids (usually used for asthma and COPD) to reduce the chances of severe respiratory illness in COVID-19 patients. Mona Bafadhel is Associate Professor of Respiratory Medicine at the University of Oxford and a Consultant Respiratory Physician. Her research focuses on chronic obstructive pulmonary disease (COPD), a set of conditions that cause the airways to become inflamed and make it harder for patients to breathe. In this event, Mona talks about: – The background to the STOIC study (Steroids in Covid Study) – Early clinical observations that respiratory disease was an infrequent finding in people hospitalised with COVID-19 – Early laboratory findings that viral replication seemed to be reduced by inhaled corticosteroids – What we already know about asthma, COPD and viruses – The STOIC Study design – who was eligible to volunteer – What happened during the study – The study outcomes – primary and secondary endpoints – Data on the study volunteers and their symptoms – Results of the study – primary and secondary endpoints – Strengths and limitations of the study – Q&A More information: https://clinicaltrials.gov/ct2/show/NCT04416399 https://www.ndm.ox.ac.uk/team/mona-bafadhel

Prof Ian Pavord, Professor of Respiratory Medicine at the University of Oxford’s Nuffield Department of Medicine, discusses research into eosinophilic airway inflammation at the Respiratory Colloquium (RESCO) in Sydney on 22 February 2020. Prof Pavord is the Respiratory Theme Lead for the Oxford Biomedical Research Centre.

Prof Ian Pavord, Professor of Respiratory Medicine at the University of Oxford’s Nuffield Department of Medicine, discusses research into eosinophilic airway inflammation at the Respiratory Colloquium (RESCO) in Sydney on 22 February 2020. Prof Pavord is the Respiratory Theme Lead for the Oxford Biomedical Research Centre.

Prof Ian Pavord, Professor of Respiratory Medicine at the University of oxford’s Nuffield Department of Medicine, describes recent efforts to transform classifications and treatment of chronic airways conditions, including asthma and COPD. He was speaking at the first of a series of workshops and seminars on personalised medicine at St Anne's College, Oxford, on 21 March 2019, jointly organised by the Centre for Personalised Medicine and the NIHR Oxford Biomedical Research Centre's Partnerships for Health, Wealth and Innovation Theme. The event aimed to identify major social challenges around personalised medicine – developing new knowledge, tools and solutions. Prof Pavord is the Respiratory Theme Lead for the Oxford Biomedical Research Centre.

The neuroscientists from the Breathe Oxford group are investigating what parts of your brain are involved in feeling breathlessness. Meet the team and find out whether being out of breath is 'all in the mind'.

Our understanding of asthma and other airways diseases has developed significantly in recent years, but this has not necessarily translated into improved treatments for many people living with these conditions. Speaking at the Oxford BRC’s Open Day in May 2019, Prof Ian Pavord, the BRC’s Theme Lead for Respiratory Medicine, explained that the discovery of biomarkers such as eosinophilic airway inflammation should lead to a more stratified and targeted approach to treating patients. Prof Pavord was joined by Beth Noray, an asthma patient who has taken part in clinical trials, who gave her perspective on what participating in research has meant to her and how she views her condition.

Peter McQuitty was diagnosed with asthma at the age of 2, but treatments at that time did not help him. In this #SevereAsthma video, she tells u how he was taken out of school, he saw many, many doctors, but their diagnosis and treatments did not make him get better. Recent research has led scientists to better define asthma, improve diagnosis and develop better therapies so patients have a better quality of life. We hope all asthma patients be able to control their asthma soon. Severely, ASTHMA! is a 2018 a video series portraying six real severe asthma patients and their families throughout Europe, each bringing a unique insight on diagnosis, care, social and family life, being young with asthma, participating in research and living with air pollution. More information: http://www.efanet.org/resources/library/3499-severely-asthma Erratum: the asthma nurse who appears in the video is Katie Borg, instead of Katie Bores

Dr Rahman is Clinical Director of the Oxford Respiratory Trials Unit. Here he discusses the challenges of respiratory medicine in the UK.

This video from the Oxford Imaging Trials Unit (OITU) provides information about the xenon MRI research programme led by Professor Fergus Gleeson. The video features lead Co-Investigator Dr Tahreema Matin, MRI Superintendent Radiographer Anthony McIntyre and Respiratory Research Nurse Tara Harris describing the novel lung imaging technique. The video also features a research study participant, describing his experience and journey through the clinical trial. For further information please see: – https://oxfordbrc.nihr.ac.uk/translational/xenon-lung-imaging/ This film was produced by Oxford Medical Illustration part of Oxford University Hospitals NHS Trust. Find out more about OMI here: http://oxfordmi.nhs.uk/OMI

Professor Ian Pavord – Professor of Respiratory Medicine, University of Oxford, discusses the precision management of airways disease. From the Precision Medicine and Digital Health Technology Showcase on 27/6/17 at the Said Business School, Oxford.

Our Respiratory Theme Lead, Prof Ian Pavord explains why we need a sea-change in the way that asthma is diagnosed, categorised and treated. Prof Pavord is co-chair of a special Lancet Commission on asthma, which says that progress in treating the condition has stagnated over the past 10 years, despite recent breakthroughs, such as the use of biomarkers, which can deliver more precise and targeted treatment.